Here’s how the next generation of obesity drugs getting closer to patients differs from Wegovy and Zepbound
www.marketwatch.com
#Eli #Lilly #Novo #Nordisk #file #competing #weightloss #drugs #FDA #game #changers #obesity #medicine
Eli Lilly, Novo Nordisk file competing new weight-loss drugs with the FDA that could be game changers in obesity medicine
